Martinos Center researcher Eric Gale, PhD, is a recipient of this year’s HMS Blavatnik Therapeutics Challenge Award (BTCA). The BTCA program is designed to accelerate the development of therapeutics within Harvard Medical School (HMS) and its affiliated hospitals, with the specific goal of produc...
Search Results: Chronic Kidney Disease
The Center’s Yingying Ning Recognized for Her Work on Imaging Tissue Fibrogenesis
Yingying Ning, a postdoctoral fellow in the Caravan Lab at the Martinos Center for Biomedical Imaging, received the Young Investigator Award at the World Molecular Imaging Congress (WMIC) last month. The award recognizes Dr. Ning’s robust work in developing molecular magnetic resonance (MR) pr...
Peter Caravan
Peter Caravan, PhD, is co-director of the Institute for Innovation in Imaging (I3) at Massachusetts General Hospital and a Professor of Radiology at Harvard Medical School. He leads a multidisciplinary and translational molecular imaging lab (the Caravan Lab) focused on the invention of novel mol...
Publications Updates
May 11, 2020 The presubiculum links incipient amyloid and tau pathology to memory function in older persons Jacobs HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, Locascio J, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA. Neurology. 2020 May 5;94(18):e1916-e1928. doi: 10.1212/WNL.00...
Yinching (Iris) Chen
Y. Iris Chen, PhD, is an Assistant Professor at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital and Harvard Medical School in Boston, MA. She received her PhD in radiology science from the Harvard-MIT Health Sciences and Technology program and the department of radiol...
Advances in MRI Technologies for Chronic Liver Diseases
Iris Y. Zhou, Onofrio A. Catalano and Peter Caravan review a host of functional and molecular MRI techniques.
Novel Evaluation of Cerebrovascular Response in Chronic Mild TBI
Acupuncture Yields Improved Outcomes in Carpal Tunnel Syndrome
Though the practice of acupuncture predates current understanding of physiology by several millennia, it often provides measureable improvements in health outcomes, particularly in the area of chronic pain. Now, in a study reported in the journal Brain, a team of investigators based at the Athino...
PET/MRI Reproducibly Discriminates between Individuals with and without Chronic Low Back Pain
White Matter Changes Could Predict Cognitive Decline in Alzheimer’s Disease
Alzheimer’s disease is diagnosed based on abnormal pathology of two proteins in the brain: amyloid and tau. Research suggests, however, that other factors may also play a role. In a paper published online this week in the journal Neurology, a team of investigators at the Athinoula A. Martinos Cen...
Vitaly Napadow
Vitaly Napadow is a Professor at Harvard Medical School and the Director of the Scott Schoen and Nancy Adams Discovery Center for Recovery from Chronic Pain at Spaulding Rehabilitation Hospital and the Director of the Center for Integrative Pain NeuroImaging (CiPNI)) at the Martinos Center for Bi...
Moving Beyond Biopsy for Liver Fibrosis
Chronic liver disease is a growing health concern in the U.S. and around the world, with links to alcoholism, diabetes and even obesity. One of the early manifestations of the disease is fibrosis, an excessive buildup of scar tissue that results from repeated injury to the liver. While its effect...
Deep Learning Algorithm Can Measure Disease Severity and Change on a Continuous Spectrum
Clinicians often use imaging to evaluate both the severity and progression of disease, in many cases by assigning severity to one of several categories based on the imaging findings and seeing whether and how the classification changes on follow-up. This approach can have its limits, though. B...
David Salat
The overarching aim of Dr. Salat's work is to understand mechanisms of neural disease and to implement novel approaches to reduce the impact of disease on the brain, cognition and clinical status. Clinically, there are two main clinical foci to his research. At the MGH Martinos Center, he directs...
Iman Aganj
Dr. Aganj's research objectives are focused on developing new medical image analysis techniques and improving existing ones so researchers and clinicians can extract the maximal amount of useful information from the images they acquire, with the goal of improving human health. These efforts range...
The Past, Present and Future of Molecular Imaging @ Martinos
Over the past several months, the MGH Martinos Center has been both celebrating the past and looking toward the future of its molecular imaging effort – with a symposium held last fall and now a series of initiatives designed to bolster the molecular imaging community. While there has always b...
Hsiao-Ying Wey Receives 2016 New Investigator Award in Alzheimer’s Disease
The American Federation for Aging Research (AFAR) has awarded Hsiao-Ying (Monica) Wey, PhD, an investigator in the MGH Martinos Center and assistant professor at Harvard Medical School,with a 2017 New Investigator Award in Alzheimer’s Disease. The program is funded by The Rosalinde and Arthur ...
Deep Learning Offers Quantitative Means of Monitoring Disease Progression in Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is an eye disorder affecting roughly two-thirds of premature infants weighing less than 250 g at birth and one of the leading causes of childhood blindness worldwide. Historically, clinical diagnosis of ROP has been subjective, resulting in considerable variabilit...
Eva-Maria Ratai
Dr. Eva-Maria Ratai has been Director of Clinical Magnetic Resonance Spectroscopy at Massachusetts General Hospital (MGH) since 2003. After completing her doctoral thesis in physical chemistry at the University of Münster in Germany in 2000, and her first post-doctoral position in the Department ...
Michael Placzek
Dr. Placzek's research focuses on studying human brain diseases with translational molecular imaging - positron emission tomography (PET). Through a multi-faceted approach, his group is working towards a better understanding of the molecular mechanisms involved in brain diseases. Their work is ap...